• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    WDSrx Expands Warehouse Network

    Piramal Inks Clinical Supply Deal with Theratechnologies

    Recipharm Signs Manufacturing Deal with Enzymatica

    CDMO Northway Biotech Expands in U.S.

    Global Biosciences Co. Selects ValGenesis VLMS
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WDSrx Expands Warehouse Network

    Piramal Inks Clinical Supply Deal with Theratechnologies

    Recipharm Signs Manufacturing Deal with Enzymatica

    CDMO Northway Biotech Expands in U.S.

    Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Improving Product Profitability

    CDMO Northway Biotech Expands in U.S.

    Global Biosciences Co. Selects ValGenesis VLMS

    Nexelis Acquires GSK Vax Lab in Marburg

    The Future of Clinical Trials Series: Part I
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Syngene

    Cytovance Biologics

    Aphena Pharma Solutions

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Reed-Lane

    Flow Sciences

    PCI Pharma Services

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    What is Your Capacity?

    Context is the key to understanding and answering this difficult question properly.

    What is Your Capacity?
    Related CONTENT
    • JS Bio and Etta Biotech Advancing Partnership
    • Cognate BioServices Announces Major Expansion
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Charles River Partners with JADE
    • LSNE Expands Fill Finish and Lyophilization Ops
    John S. Ross, Mayne Pharma USA09.09.20
    Capacity at a contract pharmaceutical development and manufacturing organization (CDMO) is important to understand.  

    Questions about capacity have become more commonplace lately in the midst of the COVID-19 pandemic. Clients know that many CDMOs have reallocated laboratory and production personnel to minimize employees’ risk to potential contagion, or, in some cases, been impacted by brief inventory constraints of Personal Protective Equipment (PPE) and other consumables.

    What isn’t necessarily asked directly, but definitely is driving their queries, is what will happen when a vaccine for COVID-19 is approved for use in the general population. What will capacity be like then, when the entire world anxiously awaits the vaccine to be produced and distributed?  

    The question, “What is your capacity?” is one that all CDMOs were challenged to answer even before the pandemic. Regardless of the pandemic or any other consideration, the practical response is, “It depends.”

    I contend that if a CDMO responds with “3 billion doses” or “60 percent” or something similarly simple, then the inquiring client really should question that CDMO’s understanding of their business. The informed CDMO will answer by asking more questions in order to provide a comprehensive, directly applicable, and accurate response.

    The question, while it seems simple enough, cannot be addressed easily, quickly and without a good level of detail. 

    Why is that?
    Well, when we consider capacity at our business, we must take into account nearly 250,000 square feet of facility space with many rooms of varied capabilities; more than 500 employees of differing skills working in multiple functional areas; a diverse fleet of instruments, equipment and machinery; on-hand quantities of supplies, raw materials and consumables with differing replenishment cycles; etc.—all working in tandem to produce batches of multiple sizes and strengths of different molecules and formats for dozens of clients worldwide. It’s a complex weave of parameters to properly assess the output of any given process or product.

    What is your capacity?  
    It is a difficult question to answer unless you consider the full picture of interconnected activities that must coalesce to successfully operate a CDMO’s diverse environment. There are an infinite number of combinations available in an operation like ours, and a client needs the right mix of our resources to dovetail in order to complete a batch.
    So, when we examine capacity, we consider such factors as:
    • The suites in which client-centric operations will be conducted, as not all suites are created equal (more about that later);
    • The equipment needed—both fixed and portable, and of appropriate scale to complete the train for a given process or, in the case of the lab, the instrumentation needed to conduct the test;
    • Available employees with the requisite skills across necessary shifts; and
    • Materials available—here, approved and ready for use, which is challenging sometimes, because supply of novel active pharmaceutical ingredients (APIs) can be constrained in early development. API rarely is constrained in commercial manufacturing, but can experience variable lead times, especially in a pandemic.
    Complicating matters of capacity further is that ours is a highly customized environment.

    In our high-mix environment, formulations and processes are usually not standardized. Our unit operations vary by product, batch sizes and equipment requirements. And some products require special handling. For example, if an API is light sensitive, highly potent or even explosive in its nature, we must utilize suites and equipment with special capabilities.

    Every client project is different, and therefore capacity calculations differ for every client project.

    Moreover, most clients require certain anchor assets—larger capital equipment with long lead times, for which it is costly to enable a step change in output. For example, our Xcelodose 600S, which our scientists use to help clients get API into clinical studies faster, frequently operates at high levels of utilization.

    If every single client required that particular piece of equipment, it would become a constraint for the entire enterprise—much like “Herbie,” the slowest scout in the well-known Theory of Constraints book, The Goal. Then our output would be gated entirely by one bottleneck asset, which would definitely influence overall capacity.

    Our smaller, more portable pieces of equipment are available in multiples, which mitigate bottlenecks but can make pursuing standardization challenging.

    In our world of solid oral dose pharmaceuticals, analytical chemistry has a high degree of standardization—assays, dissolutions, tests for moisture and particle size, etc. Instrumentation is generally not variable while methods will be. But still, even within our laboratories, many variables exist, including personnel. We consider not just direct chemist time, but also shift structures and all support functions through which documentation flows. These functions factor into capacity also.

    We typically staff to a particular model, such as two shifts involving two operators per manufacturing room, five days per week. We can readily increase capacity in many operations simply by adding more people more hours of the week.

    Finally, we must factor in cleaning and set up. Generally, for CDMOs, the time that an equipment train or a suite is manufacturing actual product pales in comparison to the time needed to clean and set up equipment and rooms for the next process. Think of dominos, and how quickly they fall as compared to the time needed to set them up. Cleaning and set-up times are long compared to actual production for the small batches often in demand in our growing universe of orphan drugs and niche medications. 

    And under what model or approach do CDMOs improve productivity and output—and, thus, capacity?

    There’s Lean Manufacturing, the pursuit of the reduction of waste in all forms made universally known by Toyota and the Toyota production system.

    There’s Six Sigma, the pursuit of eliminating defect rates. This approach not only drives a higher standard of quality, but it also can improve capacity if your team was spending time making defective product.

    And there’s the Theory of Constraints, the pursuit of understanding the constraint in any process and eliminating it to the point that some other step in the process becomes the next constraint to tackle.

    All of these methods have merit depending upon the challenge you’re trying to solve. 

    At Metrics Contract Services, we ultimately reduce these variable factors down to hours as the common basis on which to measure capacity and utilization across people, equipment and rooms. We rough cut capacity multiple months in advance to drive resource and capital planning. And we rely upon near-term scheduling, which involves appropriate functional units that must coalesce to successfully complete a set of activities associated with a batch or a testing event.

    None of this is to say that capacity is impossible to calculate or plan for. Not at all.

    But this is to say capacity is not a quick and easy answer without proper context. 

    So, when a client asks me, “What is your capacity?” I reply, that depends on the applicable process at a point in time—and I’ll need to ask some clarifying questions to give an accurate response. 


    John S. Ross is president of Mayne Pharma USA, part of Mayne Pharma, an Australian-headquartered specialty pharmaceutical company focused on applying its 40 years of drug delivery expertise to commercialize branded and generic pharmaceuticals. Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide through its CDMO, Metrics Contract Services. Ross earned his MBA from the Ivey School of Business at the University of Western Ontario, from which he also received a bachelor’s degree in math and statistics. He has more than 25 years of experience in pharmaceutical industry marketing, sales, manufacturing, distribution, global sourcing, and supply chain management.
    Suggested For You
    JS Bio and Etta Biotech Advancing Partnership JS Bio and Etta Biotech Advancing Partnership
    Cognate BioServices Announces Major Expansion Cognate BioServices Announces Major Expansion
    Thermo Fisher Buys Novasep Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Charles River Partners with JADE Charles River Partners with JADE
    LSNE Expands Fill Finish and Lyophilization Ops LSNE Expands Fill Finish and Lyophilization Ops
    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    Capricor, Lonza Enter CAP-1002 Development Agreement Capricor, Lonza Enter CAP-1002 Development Agreement
    Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
    Alcami Expands Oral Solid Capabilities with Investment in Wilmington, NC Alcami Expands Oral Solid Capabilities with Investment in Wilmington, NC
    Fujifilm to Invest $40M in New Facility Fujifilm to Invest $40M in New Facility
    Lonza Expands Conjugation Facility in Visp Lonza Expands Conjugation Facility in Visp
    Abenza Promotes Kimball Hall to President Abenza Promotes Kimball Hall to President
    Aptar CSP Increases Capacity for Active Packaging Solutions Aptar CSP Increases Capacity for Active Packaging Solutions
    Samsung Biologics Names John Rim as President and CEO Samsung Biologics Names John Rim as President and CEO
    Aurinia and Lonza Expand Manufacturing Partnership Aurinia and Lonza Expand Manufacturing Partnership

    Related Features

    • Excipients
      Bye-Bye China?

      Bye-Bye China?

      Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.
      Michele Jermini and Enrico Polastro 11.17.20

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20


    • The Single-Use Mixing Landscape: Evaluating Your Options

      The Single-Use Mixing Landscape: Evaluating Your Options

      Adoption of single-use technologies has increased markedly in recent years and will continue to grow.
      Mark A. Sitcoske, Founder & CEO, High Purity New England 11.17.20

    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      Lonza’s Director of Commercial Development, Sean Diver, was recently named President of DCAT.
      Tim Wright, Editor, Contract Pharma 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20


    • Injectables
      Catering for the Complex

      Catering for the Complex

      The rapidly changing landscape of pharmaceutical packaging.
      Marcelo Cruz, Director Business Development and Marketing, Tjoapack 11.17.20

    • Cold Chain Management | Supply Chain
      Cold Chain Trends

      Cold Chain Trends

      There is a growing need for convenience through Direct-to-Patient and Direct-from-Patient services in clinical trials.
      Vince Paolizzi, Director of NanoCool Sales, Pelican BioThermal 11.17.20

    • Biologics, Proteins, Vaccines | Inspections | Supply Chain
      Inspecting the Unexpected

      Inspecting the Unexpected

      Preparing quality control processes for COVID-19 vaccine candidates.
      Dr. Andrea Sardella and Raffaele Pace, Stevanato Group 11.17.20


    • Scale-up/Technology Transfer
      Ensuring Quality During the Transfer and Scale Up of Rx Drugs

      Ensuring Quality During the Transfer and Scale Up of Rx Drugs

      Defining the key parameters and considerations for a successful technology transfer.
      Tom Chang, President, Bora Pharmaceutical Laboratory Co. Ltd. 11.17.20

    • Scale-up/Technology Transfer
      Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up

      Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up

      Identifying, assessing and mitigating threats at every stage of the development pipeline.
      Joe Willmot, Application Leader, H.E.L Group 11.17.20

    • Clinical Trials | Information Technology
      The Role of Electronic Monitoring in Maintaining Medication Adherence

      The Role of Electronic Monitoring in Maintaining Medication Adherence

      Digital solutions offer hope to get patients to take their medications properly.
      Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20


    • APIs
      Understanding the Importance of Crystallization Processes

      Understanding the Importance of Crystallization Processes

      Crystallization is a crucial aspect of a molecule’s development and can be used to avoid unnecessary cost, risk and development delays.
      Dr. Craig Callahan, Project Scientist, Cambrex Edinburgh 10.14.20

    • Capsules | Solid Dosage/Creams/Ointments
      Capsule Technology Trends

      Capsule Technology Trends

      A look at the capsule market with a particular focus on the factors driving increased demand in non-gelatin-based formulations.
      Julien Lamps, Product Manager, Lonza 10.14.20

    • Aseptic Processing | Fill/Finish
      A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility

      A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility

      Overcoming today’s aseptic fill-and-finish process challenges.
      Ute Schleyer, Project Manager, Site & Plant Development, Vetter 10.14.20

    Trending
    • The Future Of Clinical Trials Series: Part I
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Lonza To Exit Pharma Softgels And Liquid-Filled Hard Capsules
    • Nexelis Acquires GSK Vax Lab In Marburg
    • CDMO Northway Biotech Expands In U.S.
    Breaking News
    • WDSrx Expands Warehouse Network
    • Piramal Inks Clinical Supply Deal with Theratechnologies
    • Recipharm Signs Manufacturing Deal with Enzymatica
    • CDMO Northway Biotech Expands in U.S.
    • Global Biosciences Co. Selects ValGenesis VLMS
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    TPI Partners with Zeiss
    PPE Moves into New Manufacturing Facility
    Neurent Medical Closes $25 Million Series B Financing
    Contract Pharma

    Latest Breaking News From Contract Pharma

    WDSrx Expands Warehouse Network
    Piramal Inks Clinical Supply Deal with Theratechnologies
    Recipharm Signs Manufacturing Deal with Enzymatica
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Weleda Celebrates 100 Years By 'Opening' Its Gardens
    Happi

    Latest Breaking News From Happi

    NY's 1,4-Dioxane Law May Impact Concentrated Cleaners
    Sabinsa's Top Scientist Addresses US FDA
    Ipsy Adds New Personal Care Brand
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Soma partners with Moore & Moore in US
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lemu Group Engineers Mask-Making Machine
    Armbrust American Adds Meltblown Manufacturing
    P&G Reports 8% Sales Increase
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Siemens Healthineers’ DR Systems Cleared by FDA
    Former Medtronic Exec Appointed Zimmer Biomet's Chief Transformation Officer
    SeaSpine Launches Regatta Lateral Plates
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login